Join us to learn about Vulcan’s Utilizing the Digital Protocol (UDP), an umbrella project accelerating ICH M11 and end-user value. The protocol agreed upon between the sponsor and regulator governs all aspects of a clinical trial. ICH M11/M2, CDISC, and TransCelerate are working toward a digital form of the protocol. Vulcan UDP is bringing those components together into an FHIR-based exchange to ensure the protocol's interoperability across stakeholders.

If you are new to Vulcan UDP:

Check out this overview video for a comprehensive background to the Vulcan UDP project and a summary of our progress.

During this webinar, our panelists will:

• Give you insight into the UDP Connectathons—technical events that test development work within business processes. 

• Discuss the Schedule of Activities (SoA) as tested during the January 2025 Connectathon, demonstrating the ability to transmit using the SoA message and render on a receiving system as a SoA table (as seen in the protocol document). 

• Address the pathway to further digitization and the impact on business processes.

Panelists:

• Hugh Glover, Technical Director, Vulcan

• Mary Lynn Mercado, Global Head Protocol Delivery & US Site Head, Regulatory Writing & Submissions, Novartis 

• Dave Iberson-Hurst, USDM Product Owner, CDISC

• Chris Decker,President and CEO, CDISC